Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
News and Information for Medical Professionals
Search Diabetes In Control
 
Here is a listing of all the articles within Issue 333

Issue Name
Issue 333
Issue Description
DIC Newsletter Issue 333

Get the PDF version of the newsletter. Click the image, or click here.


Article Title
Articles Description
Beta-Blocker Drugs Found To Promote Diabetes

September 2006 - New UK research indicates that taking beta-blocker drugs to treat high blood pressure can increase the risk of developing diabetes by 50 percent, compared to newer drugs.

Test Your Knowledge Issue 333

Test Your Knowledge Issue 333

No Clear Evidence for Ultra-Low Cholesterol Targets

There is no scientifically valid evidence to support the ultra-low LDL target of 70 milligrams/deciliter for very high-risk patients. Further, they suggest that the evidence previously cited to support an LDL goal of less than 100mg/dL for high risk...

Fruit and Vegetables Cut Heart Disease Risk, Says Study

Every extra of fruit or vegetable consumed daily could cut the risk of heart disease by four percent, says a meta-analysis of almost a quarter of a million people, giving people even more reason to seek out the nutrient-rich foods.

Americans Unaware of Significance of Triglycerides

A survey conducted by the National Lipid Association (NLA) has revealed that 87% of patients are unaware of the importance of high triglycerides in risk of heart disease. Fewer than half say they have discussed the topic with their physicians.

New Joint Guidelines for CVD and Diabetes from 2 European Associations

European Society of Cardiology(ESC) and the European Association for the Study of Diabetes EASD) issue aggressive guidelines for coronary heart disease and diabetes.

Exenatide As Effective As Insulin

Patients on exenatide lost weight, while insulin patients gained weight.

Progression of Retinopathy Common Among Blacks With Type 1 Diabetes

Over a 6-year period, 56.1% of African Americans with type 1 diabetes and retinopathy showed progression of their eye disease.

Diabetes is Now Diagnosed in 1 in 523 Young People

This places diabetes among the more common chronic illnesses of youth, the researchers report, striking 1.82 children per 1,000, compared with 1.24 per 1,000 with cancer and 120 per 1,000 with asthma.

One-Third of U.S. Youth Not Physically Fit

Approximately one-third of boys and girls age 12 to 19 in the United States do not meet standards for physical fitness. Low physical fitness during adolescence tends to track into adulthood, so it becomes obvious why we are seeing more kids with type...

Antihypertensives Cut New-Onset Diabetes by a Third

A new analysis of the ASCOT study shows the clearest proof so far that antihypertensive treatment with an ACE inhibitor and calcium channel blocker limits new-onset diabetes, while treatment with a ß-blocker (atenolol), and thiazide diuretic...

Are Your Diabetic Patients Part of the 21% Who do Not Take Their Meds?

About 21 percent of individuals with diabetes do not regularly take their blood-sugar lowering, blood-pressure lowering or cholesterol-lowering pills, researchers found in study of 11,532 diabetes patients.

Role of Blood Glucose Self-Monitoring in Medicare Patients with Type 2 Diabetes

The Centers for Medicare and Medicaid Services is questioning whether or not Patients with Type 2 Diabetes benefit from self-monitoring of their blood glucose and should they pay for monitor and strips.

Efficacy of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes

Underuse of ACEI and ARB therapy in elderly patients because of the perceived lack of efficacy or a greater risk of adverse events appears unjustified.

Effect of Weight Loss on Arterial Stiffness in Type 2 Diabetes

Moderate weight loss improves arterial stiffness in type 2 diabetes.

Prevention of Hypoglycemia During Exercise in Children With Type 1 Diabetes

Suspending basal insulin during exercise in children with type 1 diabetes can effectively control hypoglycemia.

New Diabetes Drug Galvus Matches Avandia in Control of Blood Sugars

The new diabetes drug from Novartis, Galvus cuts blood sugar levels as much as GlaxoSmithKlines established medicine Avandia and without the side effects.


Navigate through Issue 333 below


Issue 333 has 17 articles
Go back to main Issue page here

Browse our other news categories below.
A. Lee Dellon, MD | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead | Did You Know | Education | Facts | Feature | Items for the Week | New Products | Newsflash | Press Releases | Studies | Test Your Knowledge | Test Your Knowledge Answers | Tools |

Diabetes In Control Advertisers

Print This Week's Newsletter
Download This Week's Newsletter
Newsletter is in Adobe format
If you don't haveAdobe Acrobat Reader , you can download it for Free here .

Free CE Available
CE Programs On Diabetes Available here



Text Advertisement


Search Articles On Diabetes In Control
Sign up for our FREE Weekly Newsletter
Current Issue
Past Issue
Privacy / Advertising With Us / Contact Us
Add us to your favorite news reader
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.